UBS Group
GUTS icon

UBS Group’s Fractyl Health GUTS Stock Holding History

UBS Group’s Portfolio GUTS Stock Details GUTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.25M Sell
131,657
-3,523
-3% -$30.1K ﹤0.01% 5526
2026
Q1 		$743K Buy
135,180
+42,348
+46% +$468K ﹤0.01% 5779
2025
Q4 		$2.45M Buy
92,832
+30,116
+48% +$582K ﹤0.01% 4779
2025
Q3 		$1.2M Buy
62,716
+60,812
+3,194% +$947K ﹤0.01% 5412
2025
Q2 		$37K Sell
1,904
-3,903
-67% -$75.7K ﹤0.01% 8023
2025
Q1 		$82.9K Sell
5,807
-1,968
-25% -$37.7K ﹤0.01% 7189
2024
Q4 		$192K Buy
7,775
+6,436
+481% +$180K ﹤0.01% 6475
2024
Q3 		$40.6K Buy
1,339
+1,061
+382% +$41.5K ﹤0.01% 6952
2024
Q2 		$14.2K Buy
+278
New +$21.5K ﹤0.01% 7525

Other funds holding GUTS

Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Catalio Capital Management
Catalio Capital Management New York $532M AUM 171.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Pale Fire Capital SE
Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return
General Catalyst Group Management
General Catalyst Group Management Cambridge, Massachusetts $189M AUM 10.96% 1-Year Est. Return
Deer Management Company
Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return
Maverick Capital
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
M28 Capital Management
M28 Capital Management Stamford, Connecticut $47.2M AUM 32.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

UBS Group's GUTS Position: Q2 2026 in Review

UBS Group reduced its Fractyl Health (GUTS) stake by 2.6% in Q2 2026, selling an estimated $30.1K and leaving 131,657 shares worth $1.25M. The position accounts for ﹤0.01% of the portfolio, ranked #5526.

UBS Group first reported a position in GUTS in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.45M in Q4 2025. 79 funds tracked by Wall St. Rank hold GUTS as of Q2 2026.

  • UBS Group held 131,657 shares of Fractyl Health worth $1.25M as of Q2 2026.
  • UBS Group sold 3,523 Fractyl Health shares in Q2 2026, an estimated $30.1K.
  • Fractyl Health made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #5526 holding.
  • UBS Group first reported a position in Fractyl Health in Q2 2024 and has held it in 9 quarters since.
  • UBS Group's Fractyl Health position peaked at $2.45M in Q4 2025.
  • 79 funds tracked by Wall St. Rank held Fractyl Health as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.